Stock Price Forecast

June 9, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Athenex Inc chart...

About the Company

We do not have any company description for Athenex Inc at the moment.

Please visit https://www.athenex.com/ for more information about the company.

CEO

Johnson Lau

Exchange

NASDAQ

Website

https://www.athenex.com/

$25M

Total Revenue

275

Employees

$1M

Market Capitalization

-0.30

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ATNX News

Athenex sees highest patent filings and grants during October in Q4 2023

20d ago, source: Pharmaceutical Technology

Athenex saw the highest growth of 199% in patent filings in October and 99% in grants in November in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 199% and grants by 32%.

Biotech bankruptcies hit a record despite sector’s recovery

4d ago, source: Seeking Alpha on MSN

Other notable biotech bankruptcies in 2023 include Athenex (ATNXQ), Impel Pharmaceuticals (OTCPK:IMPLQ), and Biocept (OTC:BIOCQ). This year, COVID-19 drug developer Humanigen (OTC:HGENQ) and cell ...

Biotech bankruptcies: what to expect in 2024 following a record year?

7d ago, source: labiotech

2023 was a year of economic uncertainty for the biotech industry, which led to a funding drought. It also held the record for ...

FDA After Chevron

12d ago, source: JD Supra

The Food, Drug, and Cosmetic Act (FDCA) empowers FDA to make regulations that have the force of law provided that they are subject to public notice and comment. But FDA often treats informal guidance ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...